F-star Therapeutics, Inc. announced that James Sandy has been appointed as Chief Development Officer, effective today. Mr. Sandy will lead the clinical development and advancement of F-star's pipeline. James brings over 35 years of experience in the pharmaceutical and biotechnology industries across all phases of drug development.

Before joining F-star Therapeutics James served as Chief Development Officer at Ellipses Pharma, Immunocore, and Creabilis Pharmaceuticals. Earlier in his career, James held senior positions with Pfizer, including Head of Development Operations and Project Management, Europe and Asia. James holds a MPhil in Statistics and Operational Research from Imperial College London.